Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ImmuCell Corporation
ICCC | US
6.48
USD-0.12
-1.82%
ICCC | US
About ImmuCell Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
6.48
Open
6.42
High
6.49
Low
6.26
ImmuCell Corporation an animal health company develops manufactures and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense a passive antibody product for the treatment of E. coli coronavirus and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk as well as to determine which quarter of the udder is mastitic; and Dual-Force First Defense including a whey protein concentrate for the nutritional and feed supplement markets. In addition it is involved in developing Re-Tain a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland Maine.
View LessICCC | US
Risk
44.6
Sharpe
0.32
Luna's Score
51/100
Recommendation
Hold
Luna says (ICCC | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
29.2%1 month
44.6%3 months
44.6%6 months
51.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.23
Debt to equity
0.68
Debt to assets
0.38
Ent. to EBITDA
-21.19
Ent. to rev.
1.87
PEG
-
Other Fundamentals
EBITDA
-633.70K
MarketCap
50.76M
MarketCap(USD)
50.76M
Div. yield
-
Op. margin
-25.34
Erngs. growth
-63.40
Rev. growth
54.90
Ret. on equity
-16.10
Short ratio
0.20
Short perc.
0.18
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.51
Range1M
0.60
Range3M
1.64
Volumes: Market Activity
Rel. volume
1.01
Price X volume
83.13K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -21.19 | 0.53 | Cheaper |
| Ent. to Revenue | 1.87 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.23 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 44.64 | 72.80 | Lower Risk |
| Debt to Equity | 0.68 | -1.23 | Expensive |
| Debt to Assets | 0.38 | 0.25 | Expensive |
| Market Cap | 50.76M | 3.66B | Emerging |
